Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 08, 2026 09:15 ET | Source: USA News Group

The Credibility Filter Wall Street Uses to Sort Biotech Winners

VANCOUVER, British Columbia, April 08, 2026 (GLOBE NEWSWIRE) -- USANewsGroup.com News Commentary — Biotechs that went public in Q1 2026 raised a median of $287.5 million each; and nearly every one...
April 08, 2026 09:00 ET | Source: MAIA Biotechnology, Inc.

MAIA Biotechnology Expects Recent $33 Million Capital Raise to Fully Fund Ongoing Pivotal Phase 3 Trial of Novel Telomere-Targeting Anticancer Therapy

Strong participation in recent $33 million common stock offering highlights investor confidence in late-stage clinical momentum and commercial potential Statistical assessments point to high...
April 08, 2026 08:58 ET | Source: Zion Market Research

$30.16+ BN Functional Service Providers Market Forecasts to 2034: Rising Trial Complexity, Cost Pressures, Demand for Flexible & Scalable Outsourcing Models

NEW YORK, USA, April 08, 2026 (GLOBE NEWSWIRE) -- Zion Market Research has published a new research report titled “Functional Service Providers Market By Type (Clinical Monitoring, Medical Writing,...
April 08, 2026 08:30 ET | Source: GRI Bio, Inc.

GRI Bio Receives Notice of Allowance for UAE Patent Application Covering Novel Type 2 Diverse NKT Cell Agonists for the Treatment of Inflammatory Conditions

Issued claims further strengthen global intellectual property portfolio supporting immune cell modulation platform and expand strategic presence in a high-growth international market LA JOLLA, CA,...
April 08, 2026 08:30 ET | Source: Equillium, Inc.

Equillium Announces Poster Presentations at IMMUNOLOGY2026™, the Annual Meeting of the American Association of Immunologists

LA JOLLA, Calif., April 08, 2026 (GLOBE NEWSWIRE) -- Equillium, Inc. (Nasdaq: EQ), a biotechnology innovator developing novel therapies to treat severe autoimmune and inflammatory disorders, today...
April 08, 2026 08:00 ET | Source: Remedy Plan Therapeutics

Remedy Plan Therapeutics Appoints Jotin Marango, M.D., Ph.D., as Chief Financial and Business Officer

GAITHERSBURG, Md., April 08, 2026 (GLOBE NEWSWIRE) -- Remedy Plan Therapeutics, a clinical-stage biotechnology company developing novel therapies that target fundamental metabolic vulnerabilities in...
April 08, 2026 08:00 ET | Source: Life Biosciences

Life Biosciences Secures $80 Million Series D Financing

BOSTON, April 08, 2026 (GLOBE NEWSWIRE) -- Life Biosciences, Inc., (“Life Bio”) a biotechnology company pioneering cellular rejuvenation therapies to reverse and prevent multiple diseases of aging,...
April 08, 2026 08:00 ET | Source: Lifecore Biomedical, Inc.

Lifecore Biomedical to Participate at 12th Annual American Biomanufacturing Summit

Lifecore Biomedical to Participate at 12th Annual American Biomanufacturing Summit
April 08, 2026 08:00 ET | Source: Artiva Biotherapeutics, Inc.

Artiva Biotherapeutics to Participate in the 25th Annual Needham Virtual Healthcare Conference

Artiva Biotherapeutics to Participate in the 25th Annual Needham Virtual Healthcare Conference
April 08, 2026 07:00 ET | Source: Immusoft

Immusoft Announces Presentation of World's First Patient Treated with an Engineered B Cell Therapy at Workshop Co-Hosted by FDA and ARM

SAN FRANCISCO, April 08, 2026 (GLOBE NEWSWIRE) -- Immusoft of CA, a clinical-stage biotechnology company pioneering engineered B cell therapies, today announced that it will present an invited...